Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized, controlled clinical trial

Annals of Internal Medicine

Volumn 124, Issue 6, 1996, Pages 548-556

  Hodis, Howard N ^a   Mack, Wendy J ^a   LaBree, Laurie ^a   Selzer, Robert H ^b   Liu, Chao Ran ^a   Liu, Ci Hua ^a   Alaupovic, Petar ^c   Kwong Fu, Helenann ^b   Azen, Stanley P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEVINOLIN; PLACEBO;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; IMAGE ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029978197     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-6-199603150-00002     Document Type: Article

References (34)

1. Blankenhorn DH, Hodis HN. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal Arterioscler Thromb. 1994;14:177-92.
2. Hodis HN, Mack WJ. Risk factor assessment, treatment strategy and prevention of coronary artery disease: the need for a more rational approach [Editorial]. J Intern Med. 1994;236 111-3
3. Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Uu CR, Liu CH, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993,88:20-8.
4. Mack WJ, Selzer RH, Hodis HN, Erickson JK, Liu CR, Liu CH, et al. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke. 1993;24:1779-83.
5. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994;111.1-11.
6. Blankenhorn DH, Johnson RL, Nessim SA, Azen SP, Sanmarco ME, Selzer RH. The Cholesterol Lowering Atherosclerosis Study (CLAS) design, methods, and baseline results Controlled Clin Trials. 1987,8.356-87
7. Blankenhorn DH. Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts JAMA 1987; 257 3233-40
8. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of colestipol-niacin on coronary atherosclerosis A 4-year follow-up JAMA 1990;264:3013-7
9. Blankenhorn DH, Selzer RH, Mack WJ, Crawford DW, Pogoda J, Lee PL, et al. Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures A comparison of different measures of treatment effect Circulation. 1992,86 1701-9.
10. Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, et al. Effects of colestipol-niacin therapy on human femoral atherosclerosis Circulation 1991;83.438-47
11. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, et ai. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS) The MARS Research Group. Ann Intern Med. 1993;119 969-76
12. Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D. DeBoer LW, Hwang I, et al. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results Online J Curr Clin Trials 23 Oct 1992; Doc No 26
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentnfuge Clin Chem 1972,18.499-502.
14. Curry MD, Alaupovic P, Suenram CA. Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays Clin Chem 1976,22.315-22
15. Curry MD, Gustafson A, Alaupovic P, McConathy WJ. Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem. 1978;24 280-6.
16. Curry MD, McConathy WJ, Fesmire JD, Alaupovic P. Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta. 1980;617:503-13
17. Curry MD, McConathy WJ, Alaupovic P, Ledford JH, Popovic M. Determination of human apolipoprotein E by electroimmunoassay Biochim Biophys Acta 1976,439:413-25
18. Alaupovic P. David Rubinstein Memorial Lecture. the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins Canadian Journal of Biochemistry. 1981,59 565-79.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986,74 1399-406.
20. Crouse JR 3d, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol. 1995,75:455-9.
21. Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Salonen JT. KAPS the effect of prayastatin on atherosclerotic progression in carotid and femoral arteries [Abstract] Circulation. 1994;90:1127
22. Geroulakos G. O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 1994,15:781-5
23. Adams MR, Nakagome H, Juergens CP, Robinson J, Keech A, Balley BP, et al. Intima-media thickness of the common carotid artery, a useful screening test prior to coronary angiography [Abstract]. Circulation. 1994,90 123
24. Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis Direct and indirect validation Arterioscler Thromb 1994,14:261-4
25. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, et al. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin Circulation 1994,90:42-9.
26. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors Circulation 1990;81:470-6
27. Patsch W, Sharrett AR, Chen IY, Lin-Lee YC, Brown SA, Gotto AM Jr, et al. Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertnglycendemic humans Arterioscler Thromb. 1994; 14 874-83.
28. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR 3d. Postprandial triglyceridernia and carotid atherosclerosis in middle-aged subjects Stroke. 1992,23:823-8
29. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipopro-tein lipase activity by apolipoproteins. Effect of apolipoprotein C-III J Ciln Invest 1985;75 384-90
30. Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIIIand AI Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest. 1986,78:1287-95
31. Windier E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglycende-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res. 1985;26:556-65
32. Shelburne F, Hanks J, Meyers W, Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J Ciln Invest. 1980,65 652-8.
33. Hodis HN, Mack WJ. Triglycende-rich lipoprotemins and progression of atherosclerosis Curr Opin Lipidol 1995,6 209-14.
34. Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Circulation. 1994;90:1679-87